LENZ Therapeutics, Inc. (LENZ)
4.53
-0.19
(-4.03%)
USD |
NASDAQ |
Sep 11, 16:00
4.53
0.00 (0.00%)
After-Hours: 16:29
LENZ Therapeutics Gross Profit (TTM) : 19.36M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.36M |
| March 31, 2026 | 19.13M |
| December 31, 2025 | 18.38M |
| September 30, 2025 | 17.30M |
| June 30, 2025 | 4.91M |
| March 31, 2025 | -0.089M |
| December 31, 2024 | -0.058M |
| September 30, 2024 | -0.037M |
| June 30, 2024 | -0.031M |
| March 31, 2024 | -0.017M |
| December 31, 2023 | -0.015M |
| September 30, 2023 | -2.233M |
| June 30, 2023 | -4.397M |
| Date | Value |
|---|---|
| March 31, 2023 | -6.457M |
| December 31, 2022 | -8.346M |
| September 30, 2022 | -6.124M |
| June 30, 2022 | -4.512M |
| March 31, 2022 | -2.548M |
| December 31, 2021 | -0.746M |
| September 30, 2021 | -0.867M |
| June 30, 2021 | -0.311M |
| March 31, 2021 | -0.212M |
| December 31, 2020 | -0.122M |
| September 30, 2020 | -0.001M |
| June 30, 2020 | -0.001M |
| March 31, 2020 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Impact BioMedical, Inc. | -1.532M |
| Enveric Biosciences, Inc. | -0.1539M |
| Ocular Therapeutix, Inc. | 45.35M |
| Liquidia Corp. | 416.18M |
| Aquestive Therapeutics, Inc. | 36.26M |